Overall, the results of the current study showed that SPHK1 was expressed more highly in breast tumors, especially in negative receptors, and its expression can be associated with higher BMI in the patients; although further investigations are needed to find out its mechanisms as well as its subsequent influence on breast tumor. This evidence concerns the gene SPHK1 and breast neoplasm.